IP Library Granted Patent US 9,351,882
Granted Patent B2
US 9,351,882 · App. 12/648,463 · Granted May 31, 2016

System for providing fluid flow to nerve tissues

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,351,882
App. No.
12/648,463
Granted
May 31, 2016
Kind
B2
Abstract

An apparatus and system for providing reduced pressure to a defect in a nerve is disclosed. The apparatus comprises a nerve conduit having a generally tubular shape that has walls including a luminal wall surrounding the tissue site to contain fluids within a luminal space between the tissue site to contain fluids within a luminal space between the tissue site and the luminal wall. The apparatus further comprises a manifold having a porous body and a connector for receiving reduced pressure, wherein the manifold is positioned within the luminal space adjacent the tissue site to distribute the reduced pressure to the defect. Additionally, a method for providing reduced pressure to a defect in a nerve is disclosed that includes implanting the nerve conduit and manifold at a site of damaged nerve tissue and applying a reduced pressure to the manifold thereby stimulating repair or regrowth of nerve tissue.

Claims (38)

1. An apparatus for providing reduced pressure to a defect of a nerve, the apparatus comprising:

a nerve conduit having an inner surface, a lumen, and pores extending through the nerve conduit, the inner surface including a portion adapted to surround the defect and another portion adapted to surround an intact portion of the nerve to contain fluids within a luminal space between the defect and the inner surface of the nerve conduit for receiving a reduced pressure, wherein the pores of the nerve conduit are sufficiently small to prevent non-nerve cells from entering the luminal space from outside the nerve conduit;

a manifold positioned in the lumen of the nerve conduit and formed of a bioabsorbable porous material having a plurality of flow channels for receiving reduced pressure and adapted to be positioned within the luminal space proximate the defect to supply reduced pressure through the plurality of flow channels to the defect; and

a connector connected to a sidewall of the nerve conduit and adapted to be fluidly coupled to the manifold and a reduced pressure source to supply reduced pressure to the manifold.

2. The apparatus of claim 1 , wherein the defect is a severed, partially severed, pinched, or degenerated nerve.

3. The apparatus of claim 1 , wherein the manifold is adapted to be positioned on a distal side of the nerve.

4. The apparatus of claim 1 , wherein the manifold is adapted to provide reduced pressure to a distal side of the nerve.

5. The apparatus of claim 1 , wherein the manifold is composed of a bioinert material.

6. The apparatus of claim 1 , wherein a portion of the manifold includes a scaffold that facilitates tissue growth.

7. The apparatus of claim 6 , wherein the scaffold is formed from a foam or gel material.

8. The apparatus of claim 6 , wherein the scaffold is a biological material selected from fibrin or collagen.

9. The apparatus of claim 6 , wherein the scaffold material comprises a bioactive agent.

10. The apparatus of claim 9 , wherein the bioactive agent is at least one of an antibiotic, an antibody and a growth factor.

11. The apparatus of claim 10 , wherein the bioactive agent is a growth hormone (GH), a bone morphogenetic protein (BMP), transforming growth factor-α (TGF-α), a TGF-β, a fibroblast growth factor (FGF), granulocyte-colony stimulating factor (G-CSF), granulocyte/macrophage-colony stimulating factor (GM-CSF), epidermal growth factor (EGF), platelet derived growth factor (PDGF), insulin-like growth factor (IGF), vascular endothelial growth factor (VEGF), hepatocyte growth factor/scatter factor (HGF/SF), an interleukin, tumor necrosis factor-α (TNF-α) or nerve growth factor (NGF).

12. The apparatus of claim 1 , wherein the manifold is substantially cylindrical in shape with a longitudinal axis extending axially through the luminal space.

13. The apparatus of claim 12 , wherein the defect is a severed nerve having severed ends with the manifold positioned between the severed ends.

14. The apparatus of claim 13 , wherein the manifold having end surfaces further comprises at least one manifold rod having a first end fluidly coupled to one of the end surfaces of the manifold and a second end extending therefrom into the luminal space.

15. The apparatus of claim 14 , wherein the manifold includes the at least one manifold rod extending only from one end surface.

16. The apparatus of claim 14 , wherein the at least one manifold rod is composed of a bioabsorbable material.

17. The apparatus of claim 14 , wherein the at least one manifold rod includes a scaffold that facilitates tissue growth.

18. The apparatus of claim 14 , wherein the at least one manifold is tubular in shape with porous walls in fluid communication with the luminal space.

19. The apparatus of claim 12 , wherein the manifold having end surfaces further comprises an opening extending between the end surfaces along the longitudinal axis of the manifold.

20. The apparatus of claim 19 , wherein the defect is a pinched nerve and the manifold is adapted to receive the pinched nerve through the opening of the manifold.

21. The apparatus of claim 20 , wherein the manifold further comprises at least one manifold rod having a first end fluidly coupled to one of the end surfaces of the manifold and a second end extending therefrom into the luminal space.

22. The apparatus of claim 21 , wherein the manifold includes the at least one manifold rod extending only from one end surface.

23. The apparatus of claim 21 , wherein the at least one manifold rod is composed of a bioabsorbable material.

24. The apparatus of claim 21 , wherein the at least one manifold rod includes a scaffold that facilitates tissue growth.

25. The apparatus of claim 1 , wherein the nerve conduit includes a slice along the length of the nerve conduit that forms an opening whereby the nerve conduit is implantable around the nerve and sealable with one or more closure elements.

26. The apparatus of claim 1 , wherein the nerve conduit is composed of a bioinert material.

27. The apparatus of claim 1 , wherein the nerve conduit is composed of a bioabsorbable material.

28. The apparatus of claim 27 , wherein the nerve conduit is composed of collagen.

29. The apparatus of claim 1 , wherein the pores have an interior diameter of between about 5 μm and 50 μm.

30. The apparatus of claim 1 , wherein the nerve conduit has a length that is greater than a length of the manifold.

31. A system for providing reduced pressure to a defect of a nerve, the system comprising:

a pressure source for supplying the reduced pressure;

a nerve conduit having an inner surface, a lumen, and pores extending through the nerve conduit, the inner surface including a portion adapted to surround the defect and another portion adapted to surround an intact portion of the nerve to contain fluids within a luminal space between the defect and the nerve conduit for receiving a reduced pressure, wherein the pores of the nerve conduit are sufficiently small to prevent non-nerve cells from entering the luminal space from outside the nerve conduit;

a manifold positioned in the lumen of the nerve conduit and formed of a bioabsorbable porous material having a plurality of flow channels for receiving reduced pressure and adapted to be positioned within the luminal space proximate the defect to supply reduced pressure through the plurality of flow channels to the defect; and

a connector connected to a sidewall of the nerve conduit and adapted to be fluidly coupled to the manifold and the pressure source to supply reduced pressure to the manifold.

Assignments (8)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2024
From: 3M INNOVATIVE PROPERTIES COMPANY
To: SOLVENTUM INTELLECTUAL PROPERTIES COMPANY
Reel/Frame 066445/0336 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 28, 2023
From: KCI LICENSING, INC.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 064730/0218 →
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Nov 7, 2019
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: KCI USA, INC.; KCI LICENSING, INC.
Reel/Frame 050966/0547 →
RELEASE OF SECURITY INTEREST REEL/FRAME 040098/0268 Recorded Feb 8, 2017
From: WILMINGTON TRUST
To: KCI USA, INC.
Reel/Frame 041666/0320 →
LIMITED THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Oct 7, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040291/0237 →
SECOND LIEN SECURITY AGREEMENT Recorded Sep 21, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040098/0268 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 12, 2010
From: SWAIN, LARRY; MANWARING, MICHAEL; LEUNG, BRADEN; CORNET, DOUGLAS
To: KCI LICENSING, INC.
Reel/Frame 023943/0627 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 12, 2010
From: SWAIN, LARRY; MANWARING, MICHAEL; LEUNG, BRADEN; CORNET, DOUGLAS
To: KCI LICENSING, INC.
Reel/Frame 023944/0578 →